SHANGHAI, CHINA -- (MARKET WIRE) -- April 16, 2007 -- SinoBiomed Inc. (the "Company") (OTCBB: SOBM) is pleased to announce that Shanghai Wanxing Bio-pharmaceuticals Co., Ltd.'s "Shanghai Wanxing" (an 82% owned subsidiary of the Company) has signed a technical cooperation agreement with Blue Blood Biotech Corp. of Taiwan ("Blue Blood Biotech").
